Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
New York, NY
SEC filing record 1 source field available
Fiscal year end
31 December
Actinium Pharmaceuticals, Inc. has filed 505 SEC EDGAR filings since 05 Feb 2007

SEC filing history

Showing 26-50 of 479 matching filings.

Per page
25
Current page
2
8-K File 001-36374

CURRENT REPORT

Filing date
09 May 2025
Reporting date
08 May 2025
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
02 Apr 2025
Reporting date
31 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
02 Apr 2025
Reporting date
31 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
02 Apr 2025
Reporting date
31 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
02 Apr 2025
Reporting date
31 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
02 Apr 2025
Reporting date
31 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
02 Apr 2025
Reporting date
31 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
02 Apr 2025
Reporting date
31 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-36374

ANNUAL REPORT

Filing date
31 Mar 2025
Reporting date
31 Dec 2024
Next action
Verify source filing
8-K File 001-36374

CURRENT REPORT

Filing date
27 Nov 2024
Reporting date
27 Nov 2024
Next action
Verify source filing
10-Q File 001-36374

QUARTERLY REPORT

Filing date
14 Nov 2024
Reporting date
30 Sep 2024
Next action
Verify source filing
SC 13G/A File 005-82467

SC 13G/A filing

Filing date
12 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-82467

SC 13G/A filing

Filing date
08 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-36374

FORM ARS

Filing date
06 Nov 2024
Reporting date
31 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
05 Nov 2024
Reporting date
01 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
05 Nov 2024
Reporting date
01 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36374

CURRENT REPORT

Filing date
05 Nov 2024
Reporting date
01 Nov 2024
Next action
Verify source filing
DEF 14A File 001-36374

PROXY STATEMENT

Filing date
05 Nov 2024
Reporting date
27 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-82467

SC 13G filing

Filing date
04 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-82467

SC 13G/A filing

Filing date
04 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-36374

QUARTERLY REPORT

Filing date
05 Aug 2024
Reporting date
30 Jun 2024
Next action
Verify source filing
8-K File 001-36374

CURRENT REPORT

Filing date
05 Aug 2024
Reporting date
05 Aug 2024
Next action
Verify source filing
10-Q File 001-36374

QUARTERLY REPORT

Filing date
26 Apr 2024
Reporting date
31 Mar 2024
Next action
Verify source filing
S-8 File 333-278395

REGISTRATION STATEMENT

Filing date
29 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-36374

ANNUAL REPORT

Filing date
29 Mar 2024
Reporting date
31 Dec 2023
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .